Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity

作者: Meimei Bao , Zhifei Cao , Di Yu , Shilong Fu , Gaochuan Zhang

DOI: 10.1016/J.TOXLET.2012.10.015

关键词:

摘要: Osteosarcoma is one of the most common malignant bone tumors in children and adolescents. Although extensive efforts have been made anti-osteosarcoma therapy recent decades, there are no effective low-toxicity drugs for treating patients with metastatic osteosarcoma. Hence, potent anti-metastatic osteosarcoma highly desired. In this study, we explored novel small molecular agents found that columbamine (COL), an active component herb Coptis chinensis, inhibited proliferation neovascularization U2OS cells. COL effectively suppressed cell vitro IC(50) 21.31±0.38μM, low cytotoxicity. Mechanistic studies revealed induces cycle arrest at G2/M transition, which associated attenuating CDK6 gene expression diminishing STAT3 phosphorylation. did not significantly promote apoptosis any dosages tested. Additionally, cell-mediated neovascularization, was accompanied by down-regulation matrix metalloproteinase (MMP) 2 reduction migration, adhesion, invasion. Taken together, our data show exerts anti-proliferative anti-vasculogenic effects on human cells toxicity. These results warrant further investigation as a potential anti-cancer drug.

参考文章(54)
Stefano Ferrari, Emanuela Palmerini, Eric L. Staals, Mario Mercuri, Bertoni Franco, Piero Picci, Gaetano Bacci, The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future. Cancer treatment and research. ,vol. 152, pp. 275- 287 ,(2009) , 10.1007/978-1-4419-0284-9_14
Mei Jiong, Jia Yongwei, Cai Xuansong, Vascular channel formation by osteosarcoma cells in vitro: Vasculogenic mimicry The Chinese-german Journal of Clinical Oncology. ,vol. 2, pp. 237- 239 ,(2003) , 10.1007/BF02835467
Veli-Matti Kosma, Risto Pirinen, Risto Johansson, Jan Böhm, Tero Leinonen, Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer. Histology and Histopathology. ,vol. 23, pp. 693- 700 ,(2008) , 10.14670/HH-23.693
Richard E. B. Seftor, Elisabeth A. Seftor, Michael S. Kinch, Kelly Carles-Kinch, Galen B. Schneider, Mary J. C. Hendrix, Angela R. Hess, Lynn M. G. Gardner, Molecular Regulation of Tumor Cell Vasculogenic Mimicry by Tyrosine Phosphorylation: Role of Epithelial Cell Kinase (Eck/EphA2) Cancer Research. ,vol. 61, pp. 3250- 3255 ,(2001)
Ruifang Liu, Zhifei Cao, Jian Tu, Yanyan Pan, Bingxue Shang, Gaochuan Zhang, Meimei Bao, Shasha Zhang, Ping Yang, Quansheng Zhou, Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry Pigment Cell & Melanoma Research. ,vol. 25, pp. 630- 638 ,(2012) , 10.1111/J.1755-148X.2012.01036.X
Wen-bin Liu, Ge-liang Xu, Wei-dong Jia, Jian-sheng Li, Jin-liang Ma, Ke Chen, Zhi-hua Wang, Yong-sheng Ge, Wei-hua Ren, Ji-hai Yu, Wei Wang, Xiu-jun Wang, Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma Medical Oncology. ,vol. 28, pp. 228- 238 ,(2011) , 10.1007/S12032-010-9706-X
Shiwu Zhang, Danfang Zhang, Baocun Sun, Vasculogenic mimicry: current status and future prospects. Cancer Letters. ,vol. 254, pp. 157- 164 ,(2007) , 10.1016/J.CANLET.2006.12.036
Chenglin Li, Na Lu, Qi Qi, Fanni Li, Yun Ling, Yan Chen, Yansu Qin, Zhiyu Li, Haiwei Zhang, Qidong You, Qinglong Guo, Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway. Biochemical Pharmacology. ,vol. 82, pp. 1873- 1883 ,(2011) , 10.1016/J.BCP.2011.09.013
Naohiro Fujimoto, Masayoshi Nomura, Tetsuro Matsumoto, Current and future status of prostate cancer chemoprevention. Expert Review of Anticancer Therapy. ,vol. 6, pp. 59- 71 ,(2006) , 10.1586/14737140.6.1.59
Qian Qian, Qian Wang, Ping Zhan, Ling Peng, Shu-Zhen Wei, Yi Shi, Yong Song, The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Investigation. ,vol. 28, pp. 661- 669 ,(2010) , 10.3109/07357901003735634